| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/07/1995 | US5395825 Medical diagnosis of infertility in females |
| 03/07/1995 | US5395824 Dipeptide derivative and prophylactic and therapeutic agent for bone diseases containing the same |
| 03/04/1995 | CA2131430A1 Microsomal triglyceride transfer protein |
| 03/04/1995 | CA2131255A1 Tocopherols |
| 03/03/1995 | CA2131074A1 Therapeutic or preventive agents for diseases associates with peroxylipid |
| 03/02/1995 | WO1995006040A1 Benzodiazepine compounds useful as antagonists of cck or of gastrine |
| 03/02/1995 | WO1995005849A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 03/02/1995 | WO1995005814A1 Pharmaceutical compositions comprising metal complexes |
| 03/02/1995 | WO1995005810A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 03/02/1995 | WO1995005752A1 Reduced absorption of fatty acids |
| 03/02/1995 | CA2170253A1 Pharmaceutical compositions comprising metal complexes |
| 03/02/1995 | CA2169210A1 Compositions and methods for the detection and treatment of protein trafficking disorders and increasing secretory protein production |
| 03/02/1995 | CA2169089A1 Benzodiazepine derivatives |
| 03/01/1995 | EP0640689A2 p40 Homodimer of interleukin-12 |
| 03/01/1995 | EP0640620A2 Methods and reagents for inhibiting cholesterol absorption in humans mediated by pancreatic esterase receptor protein |
| 03/01/1995 | EP0640593A1 Substituted benzoylguanidines, process for their preparation, their use as medicine or in diagnostic and medicines containing them |
| 03/01/1995 | EP0640590A1 Process for the synthesis of 4-mercaptophenols and naphthalenols |
| 03/01/1995 | EP0640339A1 Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs |
| 03/01/1995 | EP0640072A1 Substituted pyridines, their preparation and pharmaceutical use |
| 03/01/1995 | CN1099290A Adipsa soft extract and its preparation |
| 02/28/1995 | US5393900 Steroid intermediates for the formation of vitamin D3 analogues |
| 02/28/1995 | US5393869 Polypeptides; hormone therapy for osteoporosis, hypertension and hypoparathyroidism |
| 02/28/1995 | US5393779 Anti-obesity, hypoglycemic, adrenergic blocking agents |
| 02/28/1995 | US5393775 Benzopyran compounds |
| 02/28/1995 | US5393774 Phenylethanolamines, pharmaceutical compositions containing these compounds and process for preparing them |
| 02/28/1995 | US5393749 Method of treating osteoporosis with 1 α25-dihydroxy-22(E)-dehydro-vitamin D3 |
| 02/28/1995 | US5393748 Methylenebisphosphonic acid derivatives |
| 02/28/1995 | US5393740 Neurotensin Hexapeptides |
| 02/28/1995 | US5393535 Water in oil emulsion |
| 02/28/1995 | CA1334591C 1,4-dihydropyridine carboxylic acid ester derivatives, processes for their preparation and pharmaceutical compositions containing same |
| 02/28/1995 | CA1334589C Benzodiazepine derivatives |
| 02/28/1995 | CA1334575C Substitution fluid preparation comprising 3-hydroxybutyric acid (beta-hydroxybutyric acid) and its salts |
| 02/26/1995 | CA2130617A1 Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs |
| 02/23/1995 | WO1995005463A1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 02/23/1995 | WO1995005452A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules |
| 02/23/1995 | WO1995005376A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelin antagonists |
| 02/23/1995 | WO1995005363A1 Amidine derivatives with nitric oxide synthetase activities |
| 02/23/1995 | WO1995005191A1 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF-β ACTIVITY |
| 02/23/1995 | WO1995005187A1 Hepatoselective pharmaceutical actives |
| 02/23/1995 | WO1995005184A2 Phosphate-binding polymers for oral administration |
| 02/23/1995 | WO1995005180A1 Methods and compositions for inhibiting uridine secretion |
| 02/23/1995 | CA2402590A1 Phospate-binding polymers for oral administration |
| 02/23/1995 | CA2169360A1 Methods and compositions for stimulating and inhibiting tgf-.beta. activity |
| 02/23/1995 | CA2169280A1 Amidine derivatives with nitric oxide synthetase activities |
| 02/23/1995 | CA2165567A1 Substituted 2(5h)furanone, 2(5h)thiophenone and 2(5h)pyrrolone derivatives, their preparation and their use as endothelien antagonists |
| 02/22/1995 | EP0639644A1 New macrolides and their use |
| 02/22/1995 | EP0639575A1 Bicyclic heterocycles, medicaments comprising these compounds and processes for their production |
| 02/22/1995 | EP0639552A1 Napthalenederivatives, their preparation and pharmaceutical compositions containing them |
| 02/22/1995 | EP0639374A2 New treatments using phenethyl derivatives |
| 02/22/1995 | EP0639373A1 Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds |
| 02/22/1995 | EP0639201A1 14,16beta-ETHANO-15beta,16' -CYCLO-14beta-ESTRA-1,3,5(10)-TRIENES |
| 02/22/1995 | EP0639194A1 Cyclic ketal derivatives |
| 02/22/1995 | EP0639187A1 Phenylderivate as inhibitors of atp citrate lyase |
| 02/22/1995 | EP0639186A1 Taxol derivatives |
| 02/22/1995 | EP0639079A1 Methods for treating interleukin-1 and tumor necrosis factor mediated diseases |
| 02/22/1995 | EP0639055A1 Methods of treating obesity with purine related compounds |
| 02/22/1995 | CN1098907A Dry mix formulation for bisphosphonic acids |
| 02/21/1995 | US5391776 Steroid derivatives |
| 02/21/1995 | US5391753 Tumor inhibiting agents; useful for treating dermatological conditions and rheumatic illnesses |
| 02/21/1995 | US5391569 Treating osteoporosis, inflammatory disorders |
| 02/21/1995 | US5391565 Oxazolidine dione derivatives |
| 02/21/1995 | US5391551 Method of lowering blood lipid levels |
| 02/21/1995 | US5391550 Compositions of matter and methods for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
| 02/19/1995 | CA2129906A1 Naphthalene derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/17/1995 | CA2130044A1 Macrolides and the use thereof |
| 02/16/1995 | WO1995004821A1 Human glucagon-like 1 peptide receptor |
| 02/16/1995 | WO1995004752A1 Therapeutic peptide derivatives |
| 02/16/1995 | WO1995004720A2 Gastrin and cck receptor ligands |
| 02/16/1995 | CA2168448A1 Human glucagon-like 1 peptide receptor |
| 02/16/1995 | CA2167154A1 Gastrin and cck receptor ligands |
| 02/15/1995 | EP0638568A1 Substituted piperazines, their process of preparation and the pharmaceutical compositions containing them |
| 02/15/1995 | EP0638556A1 Medicaments containing 1-Thiocarbamoyl-5-hydroxy pyrazoles and their use as agents for the treatment of septic shock |
| 02/15/1995 | EP0638317A1 Pharmaceutical composition |
| 02/15/1995 | EP0638075A1 Thiazole or imidazole derivatives as maillard reaction inhibitors |
| 02/15/1995 | EP0638061A1 Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness |
| 02/15/1995 | EP0637959A1 Soluble analogs of probucol |
| 02/15/1995 | CN1098715A 1H-indole-3-acetamide spla2 inhibitors |
| 02/15/1995 | CN1098714A 1H-indole-3-acetic acid hydrazide spla2 inhibitors |
| 02/15/1995 | CN1098624A Pharmaceutical preparation containing L-aspartate or L-asparagine for preventing ethanol toxicity, and process for preparation thereof |
| 02/14/1995 | US5389684 Naphthalene carboxamides |
| 02/14/1995 | US5389668 Thiochroman compounds |
| 02/14/1995 | US5389610 Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors |
| 02/14/1995 | US5389359 Pharmaceutical preparation containing L-aspartate or L-asparagine for preventing ethanol toxicity, and process for preparation thereof |
| 02/14/1995 | CA2129763A1 Insulin formulation |
| 02/14/1995 | CA1334409C Diphosphonic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| 02/12/1995 | CA2129701A1 Medicaments containing 1-thiocarbamoyl-5-hydroxy-pyrazoles and their use as agents for combating septic shock |
| 02/09/1995 | WO1995004047A1 2-benzoheterocyclyloxy or thiopropanolamine derivatives with adreno receptor agonist activity |
| 02/09/1995 | WO1995004045A1 Compounds as pde iv and tnf inhibitors |
| 02/09/1995 | WO1995004036A1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors |
| 02/09/1995 | WO1995004028A1 Indane and tetrahydronaphthalene derivatives as calcium channel antagonists |
| 02/09/1995 | WO1995004027A1 Aminoindanes and related compounds useful as calcium-channel antagonists |
| 02/09/1995 | WO1995003780A1 Cosmetic or pharmaceutical and particularly dermatological composition containing an extract of tephrosia, particularly tephrosia purpurea |
| 02/09/1995 | WO1995003764A1 Skin patches and methods for providing testosterone |
| 02/09/1995 | WO1994022437A3 Method for treating amyloidosis |
| 02/09/1995 | DE4428025A1 Inhibitoren der Acyl-Enzym-A-Cholesterin-O-Acyl-Transferase mit therapeutischer Wirksamkeit, ihre Verwendung und sie enthaltende pharmazeutische Zusammensetzungen Inhibitors of acyl-enzyme A: cholesterol O-acyl transferase with therapeutic efficacy, their use and pharmaceutical compositions containing them |
| 02/09/1995 | CA2168257A1 Aminoindanes and related compounds useful as calcium-channel antagonists |
| 02/09/1995 | CA2168044A1 Cosmetic or pharmaceutical and particularly dermatological composition containing an extract of tephrosia, particularly tephrosia purpurea |
| 02/09/1995 | CA2153236A1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors |
| 02/08/1995 | EP0637592A1 Processes of producing amylase inhibitors |
| 02/08/1995 | EP0637308A1 Benzodiazepine derivatives, compositions containing them and their use in therapy |